Related Experiment Video
Updated: Oct 6, 2025

Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 Kir4.1
Published on: September 26, 2015
DNA Methylation and Non-Coding RNAs during Tissue-Injury Associated Pain
Jahanzaib Irfan1, Muhammad Rizki Febrianto1, Anju Sharma1
1Nociception Group, Department of Surgery and Cancer, Division of Anaesthetics, Pain Medicine and Intensive Care, Chelsea and Westminster Hospital Campus, Imperial College London, 369 Fulham Road, London SW10 9FJ, UK.
Abstract:
While about half of the population experience persistent pain associated with tissue damages during their lifetime, current symptom-based approaches often fail to reduce such pain to a satisfactory level. To provide better patient care, mechanism-based analgesic approaches must be developed, which necessitates a comprehensive understanding of the nociceptive mechanism leading to tissue injury-associated persistent pain. Epigenetic events leading the altered transcription in the nervous system are pivotal in the maintenance of pain in tissue injury. However, the mechanisms through which those events contribute to the persistence of pain are not fully understood. This review provides a summary and critical evaluation of two epigenetic mechanisms, DNA methylation and non-coding RNA expression, on transcriptional modulation in nociceptive pathways during the development of tissue injury-associated pain. We assess the pre-clinical data and their translational implication and evaluate the potential of controlling DNA methylation and non-coding RNA expression as novel analgesic approaches and/or biomarkers of persistent pain.
Insights
Persistent pain affects many, but current treatments are insufficient. This review explores epigenetic mechanisms like DNA methylation and non-coding RNA in pain pathways, offering potential new analgesic targets.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Persistent pain, often linked to tissue damage, affects a significant portion of the population.
- Current pain management strategies primarily focus on symptoms and often yield suboptimal patient outcomes.
- Understanding the underlying mechanisms of persistent pain is crucial for developing effective, mechanism-based analgesics.
Purpose of the Study:
- To review and critically evaluate the role of epigenetic mechanisms in persistent pain.
- To explore DNA methylation and non-coding RNA expression in modulating nociceptive pathways.
- To assess the translational implications of these epigenetic mechanisms for novel pain therapies.
Main Methods:
- Comprehensive literature review of pre-clinical data on epigenetic modifications in pain.
- Analysis of transcriptional modulation in nociceptive pathways.
- Evaluation of the potential of targeting epigenetic mechanisms for pain management.
Main Results:
- Epigenetic events, including DNA methylation and non-coding RNA expression, significantly influence gene transcription in the nervous system.
- These epigenetic modifications are pivotal in the maintenance and persistence of tissue injury-associated pain.
- Pre-clinical evidence suggests these mechanisms are conserved and hold translational potential.
Conclusions:
- Epigenetic mechanisms are key drivers in the development and persistence of chronic pain.
- Modulating DNA methylation and non-coding RNA expression presents promising avenues for novel analgesic strategies.
- These epigenetic factors may also serve as valuable biomarkers for persistent pain conditions.
Related Concept Videos
Nociception
Analgesia and Pain Management
Epigenetic Regulation
X-chromosome...
Pain

